CAS 35978-75-7
:N-acétyl-L-alanine P-nitroanilide*cristalline
- Ac-Ala-pNA
- N~2~-acetyl-N-(4-nitrophenyl)-L-alaninamide
Ac-Ala-pNA
CAS :AANA, substrate for acylaminoacyl peptidases (APH, acyl peptide hydrolase), an enzyme able to degrade monomeric and oligomeric amyloid peptidesFormule :C11H13N3O4Degré de pureté :> 99%Couleur et forme :Light Yellow PowderMasse moléculaire :251.24AC-ALA-PNA
CAS :Formule :C11H13N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :251.2386Acetyl-L-alanine 4-nitroanilide
CAS :Formule :C11H13N3O4Degré de pureté :≥ 97.0%Couleur et forme :Off-white to pale yellow powderMasse moléculaire :251.24AC-ALA-PNA
CAS :Produit contrôléApplications AC-ALA-PNA (cas# 35978-75-7) is a useful research chemical.
Formule :C11H13N3O4Couleur et forme :Light YellowMasse moléculaire :251.24N-Acetyl-L-alanine 4-nitroanilide
CAS :N-Acetyl-L-alanine 4-nitroanilide is a drug that belongs to the class of drugs called anticholinergics. It is used to treat various symptoms, such as asthma and other respiratory disorders, chronic obstructive pulmonary disease, emphysema, bronchitis, and other lung diseases. N-Acetyl-L-alanine 4-nitroanilide has been shown to have clinical relevance in the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. The drug can also be used to treat clinical studies involving intubation. Drug interactions are possible with cardiac medications and antihistamines. It should not be taken by people who have a body mass index over 30 or those who have a history of cardiac problems or heart disease. The drug also interacts with heparin and nitrates, which can lead to an increased risk of irregular heartbeat or chest pain.
Formule :C11H13N3O4Degré de pureté :Min. 95%Couleur et forme :Off-White PowderMasse moléculaire :251.24 g/mol




